Adaptive Biotechnologies
Melanie O'Fallon is a seasoned sales professional in the biotechnology and pharmaceutical industries, currently serving as a Key Account Manager for Diagnostic Sales at Adaptive Biotechnologies Corp. since December 2021, where responsibilities include expanding the clonoSEC in strategic accounts. Prior experience includes a successful tenure as an Oncology Sales Manager at MorphoSys, where Melanie ranked in the top 10% following the launch of Monjuvi, and as a Senior Cell Therapy Account Specialist at Kite Pharma, focusing on developing commercial marketing plans and fostering relationships with medical professionals. Earlier roles at Gilead Sciences, Bristol-Myers Squibb, and various companies showcased expertise in oncology and neuroscience sales, cultivating key opinion leaders, and driving overall business growth. Melanie holds a Bachelor of Arts in Business Administration & Communications from Hope College and an additional Bachelor of Arts from Colorado State University.
This person is not in any teams
This person is not in any offices
Adaptive Biotechnologies
15 followers
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.